🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This drug-drug interaction study will evaluate the impact of two different ...
Status
Completed
Location
Covance Clinical Research Unit
Start Date
2017-09-21
Trial ID
NCT03302845
Treatments Being Tested
Renal excretion is a minor elimination route of telotristat etiprate. So th...
Status
Completed
Location
A.T.C. s.a., Clinical Pharmacology Unit, CHU Sart-Tilman
Start Date
2018-02-09
Trial ID
NCT03442725
Treatments Being Tested
This is a study to determine if a certain drug, called telotristat ethyl (X...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-01
Trial ID
NCT04672876
Treatments Being Tested
This phase II trial studies the effect of retifanlimab and telotristat ethy...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-03-01
Trial ID
NCT04776876
Treatments Being Tested
This study is designed to evaluate the effect of severe hepatic impairment ...
Status
Completed
Location
Lexicon Investigational Site
Start Date
2017-11-28
Trial ID
NCT03423446
Treatments Being Tested
The primary objective of the study is to estimate the proportion of carcino...
Status
Completed
Location
RTI-HS
Start Date
2017-06-22
Trial ID
NCT03223428
Treatments Being Tested
This phase II trial studies how well telotristat ethyl works in promoting w...
Status
Completed
Location
Emory University Hospital Midtown
Start Date
2019-04-17
Trial ID
NCT03910387
Treatments Being Tested
The NET-PACS trial is a Prospective Assessment of patients with neuroendocr...
Status
Withdrawn
Location
University of Iowa Hospital and Clinics
Start Date
2021-03-03
Trial ID
NCT04713202
Treatments Being Tested
This pilot trial studies how well telotristat etiprate works in treating pa...
Status
Completed
Location
Wayne State University/Karmanos Cancer Institute
Start Date
2018-06-20
Trial ID
NCT03453489
This is a randomized phase III clinical trial of Lanreotide combined with T...
Status
Withdrawn
Location
Multiple Locations
Start Date
2020-04
Trial ID
NCT04065165
Treatments Being Tested